p53 Antibody FITC MA1-19551 from Thermo Fisher Scientific

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

(1) Müllerian precursor lesions in serous ovarian cancer patients: using the SEE-Fim and SEE-End protocolModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncJuly 1, 2014Mingels MJ, van Ham MA, de Kievit IM, Snijders MP, van Tilborg AA, Bulten J, Massuger LF.

(2) The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerizationThe Journal of biological chemistryMay 23, 2014Cubillos-Rojas M, Amair-Pinedo F, Peiró-Jordán R, Bartrons R, Ventura F, Rosa JL.

(5) Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosityNeuropathology and applied neurobiologyFebruary 1, 2014Baumgarten P, Harter PN, Tönjes M, Capper D, Blank AE, Sahm F, von Deimling A, Kolluru V, Schwamb B, Rabenhorst U, et al.

(6) Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancerModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncNovember 1, 2013Bosse T, ter Haar NT, Seeber LM, v Diest PJ, Hes FJ, Vasen HF, Nout RA, Creutzberg CL, Morreau H, Smit VT.

(8) Integral analysis of p53 and its value as prognostic factor in sporadic colon cancerBMC cancerJune 5, 2013Sarasqueta AF, Forte G, Corver WE, de Miranda NF, Ruano D, van Eijk R, Oosting J, Tollenaar RA, van Wezel T, Morreau H.

(9) Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among IndiansTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJune 1, 2013Malhotra P, Anwar M, Nanda N, Kochhar R, Wig JD, Vaiphei K, Mahmood S.

(12) Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiformeNeuro-oncologyMay 1, 2013Rosati A, Poliani PL, Todeschini A, Cominelli M, Medicina D, Cenzato M, Simoncini EL, Magrini SM, Buglione M, Grisanti S, et al.

(13) Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancerClinical cancer research : an official journal of the American Association for Cancer ResearchMarch 1, 2013Ko E, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.

(15) Vitiligo: is it grace or curse?Acta dermatovenerologica Croatica : ADCJanuary 1, 2013Bakry OA, Hammam MA, Abdel Wahed MM.

(16) Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7Nature chemical biologyJanuary 1, 2013Zhang Y, Zhou L, Rouge L, Phillips AH, Lam C, Liu P, Sandoval W, Helgason E, Murray JM, Wertz IE, et al.

(17) Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potentialPloS oneJanuary 1, 2013Mosoyan G, Nagi C, Marukian S, Teixeira A, Simonian A, Resnick-Silverman L, DiFeo A, Johnston D, Reynolds SR, Roses DF, et al.

(19) "A ""twist box"" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation"Cancer cellSeptember 11, 2012Piccinin S, Tonin E, Sessa S, Demontis S, Rossi S, Pecciarini L, Zanatta L, Pivetta F, Grizzo A, Sonego M, et al.

(20) Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activationGynecologic oncologySeptember 1, 2012Nout RA, Bosse T, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, van Eijk R, Ter Haar NT, Smit VT.

Flow